Hunter C. Smith - 29 Dec 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Hunter Smith
Issuer symbol
RYTM
Transactions as of
29 Dec 2023
Net transactions value
+$72,240
Form type
4
Filing time
03 Jan 2024, 16:15:32 UTC
Previous filing
07 Dec 2023
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $72,240 +10,500 +17% $6.88 71,906 29 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Options Exercise $0 -10,500 -9.5% $0.000000 100,594 29 Dec 2023 Common Stock 10,500 $6.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options is fully vested.